(Q30454278)

18 August 2017

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells (English)

1 reference

18 August 2017

H M Zarour

1

1 reference

18 August 2017

J M Kirkwood

2

1 reference

18 August 2017

L S Kierstead

3

1 reference

18 August 2017

W Herr

4

1 reference

18 August 2017

V Brusic

5

1 reference

18 August 2017

C L Slingluff

6

1 reference

18 August 2017

J Sidney

7

1 reference

18 August 2017

A Sette

8

1 reference

18 August 2017

W J Storkus

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Proceedings of the National Academy of Sciences of the United States of America

18 August 2017

1 reference

18 August 2017

97

1 reference

18 August 2017

1

1 reference

18 August 2017

400-405

1 reference

Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

CD4 T cells and their role in antitumor immune responses

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Several common HLA-DR types share largely overlapping peptide binding repertoires

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=26675

Neural network-based prediction of candidate T-cell epitopes.

20 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95).

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

The role of CD4+ T cell responses in antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

Production of stable cytolytic T-cell clones directed against autologous human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.1.400

HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10618430

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10618430

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.97.1.400

1 reference

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

10618430

1 reference